CALITHERA BIOSCIENCES INC (CALA) Forecast, Price Target & Analyst Ratings
NASDAQ:CALA • US13089P5070
0.3651 USD
-0.04 (-10.95%)
At close: Feb 1, 2023
0.3401 USD
-0.02 (-6.85%)
After Hours: 2/1/2023, 8:04:28 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CALITHERA BIOSCIENCES INC (CALA).
Forecast Snapshot
Consensus Price Target
$5.10
+ 1,296.88% Upside
Next Earnings Forecast
Release DateMar 29, 2023
PeriodQ4 / 2022
EPS Estimate-$1.52
Revenue Estimate
ChartMill Buy Consensus
84.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 1,296.88%
From current price of $0.37 to mean target of $5.10, Based on 10 analyst forecasts
Low
$2.02
Median
$5.10
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
-65.12%
Price Target Summary
10 analysts have analysed CALA and the average price target is 5.1 USD. This implies a price increase of 1296.88% is expected in the next year compared to the current price of 0.3651.
The average price target has been revised downward by 65.12% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
CALA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CALA.
In the previous month the buy percentage consensus was at a similar level.
CALA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-15 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-11-15 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-29 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-08-16 | SVB Leerink | Maintains | Outperform |
| 2022-05-11 | Wells Fargo | Maintains | Equal-Weight |
| 2022-01-31 | Ladenburg Thalmann | Initiate | Buy |
| 2022-01-20 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-11-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 29, 2023
PeriodQ4 / 2022
EPS Estimate-$1.52
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q68.34%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
11.13%
EPS (3 Months)
11.66%
Next Earnings Summary
CALA is expected to report earnings on 3/29/2023. The consensus EPS estimate for the next earnings is -1.52 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 9.75M | -100.00% | 252.95M | 519.63M 105.43% | 800.59M 54.07% | ||||
| EBITDA YoY % growth | -92.42M -62.80% | -91.03M 1.50% | -113.953M -25.18% | -58.14M 48.98% | -59.262M -1.93% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -92.9M -62.19% | -91.39M 1.63% | -114.233M -25.00% | -44.421M 61.11% | -35.79M 19.43% | -35M 2.21% | -66.629M -90.37% | -25.981M 61.01% | 30.023M 215.56% | |
| Operating Margin | N/A | N/A | -1,171.62% | N/A | N/A | N/A | -26.34% | -5.00% | 3.75% | |
| EPS YoY % growth | -39.20 -31.54% | -26.20 33.16% | -17.20 34.35% | -5.27 69.34% | -1.52 71.08% | -1.69 -10.70% | -2.15 -27.49% | -0.79 63.51% | 0.86 209.09% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.52 68.34% | -0.53 85.35% | -0.29 81.91% | -0.28 86.15% | -0.28 81.41% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.231M 86.66% | -8.769M 36.58% | -8.33M 26.77% | -8.748M 8.17% | -9.185M 0.50% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.90%
EPS Next 5 Year
14.34%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
120.38%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CALITHERA BIOSCIENCES INC / CALA Forecast FAQ
Can you provide the average price target for CALITHERA BIOSCIENCES INC stock?
10 analysts have analysed CALA and the average price target is 5.1 USD. This implies a price increase of 1296.88% is expected in the next year compared to the current price of 0.3651.
What is the next earnings date for CALA stock?
CALITHERA BIOSCIENCES INC (CALA) will report earnings on 2023-03-29, after the market close.
What are the consensus estimates for CALITHERA BIOSCIENCES INC (CALA) next earnings?
The consensus EPS estimate for the next earnings of CALITHERA BIOSCIENCES INC (CALA) is -1.52 USD and the consensus revenue estimate is 0 USD.
How do analysts rate CALITHERA BIOSCIENCES INC (CALA)?
The consensus rating for CALITHERA BIOSCIENCES INC (CALA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.